person

Thibault C.

Country
France
Department
IUCT-Oncopole, Internal Medicine

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
80
Sites with multiple studies

Has run more than one trial at 80 of 189 partner sites.

Specializations

Myelodysplastic Syndromes

The investigator specializes in treating various forms of myelodysplastic syndromes (MDS), with particular focus on both higher-risk and lower-risk variants. Their expertise extends to managing transfusion-dependent anemia in MDS patients and exploring novel therapeutic combinations.

  • Higher-risk MDS treatment approaches
  • Lower-risk MDS management strategies
  • Novel therapeutic combinations for MDS

Hematologic Disorders

The investigator focuses on treating complex blood disorders including immune thrombocytopenia (ITP), VEXAS syndrome, and chronic myelomonocytic leukemia (CMML). Their work encompasses innovative treatment approaches for patients with various bleeding manifestations.

  • Immune thrombocytopenia management
  • VEXAS syndrome treatment
  • Higher-risk CMML therapies

Autoimmune Conditions

The investigator has developed expertise in treating warm autoimmune hemolytic anemia (wAIHA) and related autoimmune blood disorders. Their work involves evaluating novel therapeutic agents for patients who have failed conventional treatments.

  • Autoimmune hemolytic anemia treatment
  • Novel immunotherapy approaches
  • Treatment-resistant cases

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.